Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessEarningsAurobindo Pharma Q3 cons PAT at Rs 91.8cr

    Aurobindo Pharma Q3 cons PAT at Rs 91.8cr

    Aurobindo Pharma has declared its third quarter results. The company's Q3 consolidated net profit was up at Rs 91.8 crore versus loss of Rs 28.5 crore, year-on-year, YoY.

    February 07, 2013 / 19:24 IST

    Aurobindo Pharma has declared its third quarter results. The company's Q3 consolidated net profit was up at Rs 91.8 crore versus loss of Rs 28.5 crore, year-on-year, YoY.

    Its consolidated net sales were up 23% at Rs 1,552 crore versus Rs 1,263.7 crore, YoY.

    Aurobindo Pharma closed at Rs 186.55, down Rs 5.90, or 3.07%. It has touched an intraday high of Rs 195.80 and an intraday low of Rs 184.85. There were pending buy orders of 369 shares, with no sellers available.
     
    It was trading with volumes of 586,468 shares, compared to its five day average of 536,922 shares, an increase of 9.23%.

    first published: Feb 7, 2013 07:24 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347